Recent advances in molecular mechanisms of cancer immunotherapy
Simple Summary The cancer-immunity cycle is characterized by various stimulatory and
inhibitory factors, which together regulate the immune response and halt the extreme …
inhibitory factors, which together regulate the immune response and halt the extreme …
The production of monoclonal antibodies from human lymphocytes
D Kozbor, JC Roder - Immunology Today, 1983 - cell.com
Two conceptually unique approaches are currently available for the production of human
monoclonal antibodiesthe'hybridoma'technique, based on the fusion of antibody-producing …
monoclonal antibodiesthe'hybridoma'technique, based on the fusion of antibody-producing …
[引用][C] DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology
VT DeVita - 2008 - books.google.com
Acclaimed by the worldwide medical community as" a staple reference text in the medical
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
SL Morrison, MJ Johnson… - Proceedings of the …, 1984 - National Acad Sciences
We have created mouse-human antibody molecules of defined antigen-binding specificity
by taking the variable region genes of a mouse antibody-producing myeloma cell line with …
by taking the variable region genes of a mouse antibody-producing myeloma cell line with …
[图书][B] Controlled drug delivery: fundamentals and applications
J Robinson, VHL Lee - 1987 - api.taylorfrancis.com
Controlled Drug Delivery Page 1 Controlled Drug Delivery Page 2 DRUGS AND THE
PHARMACEUTICAL SCIENCES A Series of Textbooks and Monographs Edited by James …
PHARMACEUTICAL SCIENCES A Series of Textbooks and Monographs Edited by James …
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy
RW Schroff, KA Foon, SM Beatty, RK Oldham… - Cancer research, 1985 - AACR
Human anti-murine immunoglobulin responses were assessed in serum from three groups
of patients receiving murine monoclonal antibody therapy. Each of the three patient groups …
of patients receiving murine monoclonal antibody therapy. Each of the three patient groups …
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
NK Cheung, H Lazarus, FD Miraldi… - Journal of clinical …, 1987 - ascopubs.org
The murine IgG3 monoclonal antibody (MoAb) 3F8, specific for the ganglioside GD2,
activates human complement, is active in antibody-dependent cell-mediated cytotoxicity …
activates human complement, is active in antibody-dependent cell-mediated cytotoxicity …
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies
H Masui, T Kawamoto, JD Sato, B Wolf, G Sato… - Cancer research, 1984 - AACR
Monoclonal antibodies (MoAbs) were raised against epidermal growth factor (EGF)
receptors on a human epidermoid carcinoma cell line, A431. Administration of anti-EGF …
receptors on a human epidermoid carcinoma cell line, A431. Administration of anti-EGF …
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
SP Cobbold, A Jayasuriya, A Nash, TD Prospero… - Nature, 1984 - nature.com
A major aim in immunology has been to understand how the immune system evokes
characteristic responses to infection, foreign tissue grafts and tumours. The current view of …
characteristic responses to infection, foreign tissue grafts and tumours. The current view of …
Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.
TJ Kipps, P Parham, J Punt… - The Journal of …, 1985 - rupress.org
Using the fluorescence activated cell sorter to select rare IgG2a-and IgG2b-producing
variants, we developed switch variant families of hybridomas from IgG1-producing …
variants, we developed switch variant families of hybridomas from IgG1-producing …